409
Participants
Start Date
November 15, 2019
Primary Completion Date
December 31, 2026
Study Completion Date
July 30, 2027
Ablative Radiation Therapy
Undergo stereotactic radiotherapy and/or surgery to all sites of disease (oligometastases and primary prostate if previously untreated).
Standard of care
Patients continue to receive their current planned systemic therapy at the discretion of the treating physician
BCCA - Victoria, Victoria
CancerCare Manitoba, Winnipeg
QEII Health Sciences Centre, Halifax
Royal Victoria Regional Health Centre, Barrie
Health Sciences North, Greater Sudbury
Juravinski Cancer Centre at Hamilton Health Sciences, Hamilton
Kingston Health Sciences Centre, Kingston
Trillium Health Partners - Credit Valley Hospital, Mississauga
Ottawa Hospital Research Institute, Ottawa
Algoma District Cancer Program, Sault Ste. Marie
Odette Cancer Centre, Toronto
University Health Network, Toronto
CIUSSS de l'Est-de-I'lle-de-Montreal, Montreal
CHUM-Centre Hospitalier de l'Universite de Montreal, Montreal
The Jewish General Hospital, Montreal
Hotel-Dieu de Quebec, Québec
Allan Blair Cancer Centre, Regina
Saskatoon Cancer Centre, Saskatoon
Canadian Cancer Society (CCS)
OTHER
Canadian Cancer Trials Group
NETWORK